Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
CS1 plus BCMA CAR-T by BioSeedin for Multiple Myeloma (Kahler Disease): Likelihood of Approval
CS1 plus BCMA CAR-T is under clinical development by BioSeedin and currently in Phase I for Multiple Myeloma (Kahler Disease)....